BioHorizons, a medical technology company that manufactures dental implants for the replacement of missing teeth, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. The Birmingham, AL-based company, which was founded in 1995 and booked $72 million in sales for the 12 months ended March 31, plans to list on the NASDAQ under the symbol BHZN. Piper Jaffray and Jefferies & Co. are the lead underwriters on the deal, for which pricing terms and timing were not disclosed.
